<DOC>
	<DOCNO>NCT00170820</DOCNO>
	<brief_summary>The purpose study assess combination everolimus , steroid , mycophenolate mofetil associate well renal function sirolimus .</brief_summary>
	<brief_title>Efficacy Safety Switch From Sirolimus Everolimus Stable Maintenance Renal Transplant Patients Receiving Calcineurin Inhibitor Free Regimen</brief_title>
	<detailed_description />
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>First second renal transplantation ( 1 10 year posttransplant ) Treatment sirolimus + mycophenolate mofetil + steroid + ACE inhibitor angiotensin II receptor antagonist + statin Exclusion Criteria Treatment CNI azathioprine Vascular rejection biopsyproven acute rejection within 3 month prior screen Severe dyslipidemia Other protocoldefined inclusion / exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Renal transplantation , maintenance , switch , everolimus , CNI-free</keyword>
</DOC>